MOH · Molina Healthcare, Inc. · Financials

$197.80 -2.99 (-1.49%) At close · Sep 21

S&P 400 member Russell 1000 member Rebalance outlook locked

Market Cap

$10.48B

52.20M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →

Revenue

$45.43B +11.7%

FY2025

Net Income

$472M -60%

FY2025

Gross Margin

12.76% -0.9pp

FY2020

Operating Margin

1.72% -2.5pp

FY2025

Diluted EPS

$8.92 -56.3%

FY2025

Operating Cash Flow

-$535M -183.1%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	FY2026 (G)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Revenue	+12.4%	+18.5%	+12.3%	—	$44.52B	$45.43B	$40.65B	$34.07B	$31.97B	$27.77B^G	$19.42B^G	$16.83B	$18.89B	$19.88B	$17.78B	$14.18B	$9.67B	$6.59B	$5.91B	$4.54B	$4.09B	$3.67B
Interest & Dividend Income	+64.0%	+1.4%	+30.9%	—	—	—	—	—	$75M	$77M	$17M	$17M	$125M	$70M	$38M	$23M	$20M	$7M	$5.08M	$5.45M	$6.26M	$9.15M
Premiums Earned (Net)	+11.7%	+18.7%	—	—	$41.97B	$43.05B	$38.63B	$32.53B	$30.88B	$26.86B	$18.3B	$16.21B	$17.61B	$18.85B	$16.45B	—	—	—	—	—	—	—
Rental Income	—	—	—	—	$13.54M	—	—	—	—	—	—	—	—	—	—	—	—	—	$9.37M	$547K	$0	—
Cost of Revenue	+13.3%	+20.1%	—	—	$38.89B	$39.49B	$34.43B	$28.67B	$27.18B	$23.7B	$15.82B	$13.91B	—	—	—	—	—	—	—	—	—	—
Gross Profit	+11.1%	+10.2%	—	—	—	—	—	—	—	—	$2.48B	$2.3B	$2.52B	$1.81B	$1.73B	$1.53B	$1B	$843M	—	—	—	—
Gross Margin	—	—	—	—	—	—	—	—	—	—	12.76%	13.68%	13.33%	9.1%	9.7%	10.77%	10.34%	12.79%	—	—	—	—
General & Administrative	+9.2%	+15.2%	+10.1%	—	$3.03B	$3.01B	$2.74B	$2.46B	$2.31B	$2.07B	$1.48B	$1.3B	$1.33B	$1.59B	$1.39B	$1.15B	$765M	$666M	$518.62M	$393.45M	$345.99M	$276.03M
Amortization of Intangibles	+5.7%	+43.4%	+18.3%	—	—	$91M	$82M	$85M	$77M	$49M	$15M	$18M	$21M	$31M	$32M	$17M	$18M	$18M	$20.18M	$17.45M	$18.47M	$12.94M
Depreciation & Amortization	+3.5%	+17.2%	+4.5%	—	$168M	$195M	$186M	$171M	$176M	$131M	$88M	$89M	$127M	$178M	$182M	$126M	$134M	$94M	$78.76M	$74.38M	$60.77M	$38.11M
Restructuring Charges	—	—	—	—	—	—	—	—	—	—	—	—	$8M	$150M	—	—	—	—	—	—	—	—
Total Costs & Expenses	+13.2%	+19.5%	+12.5%	—	$44.32B	$44.65B	$38.94B	$32.5B	$30.8B	$26.75B	$18.35B	$15.79B	$17.76B	$20.44B	$17.48B	$13.79B	$9.47B	$6.45B	$5.87B	$4.4B	$3.98B	$3.62B
Operating Income	-12.7%	-6.2%	+7.3%	—	$203M	$781M	$1.71B	$1.57B	$1.17B	$1.02B	$1.08B	$1.04B	$1.13B	-$555M	$306M	$387M	$193M	$137M	$41.09M	$135.82M	$105M	$51.93M
Operating Margin	—	—	—	—	—	1.72%	4.2%	4.62%	3.67%	3.67%	5.55%	6.2%	5.99%	-2.79%	1.72%	2.73%	2%	2.08%	0.69%	2.99%	2.57%	1.42%
EBITDA	-10.2%	-3.5%	+6.6%	—	$371M	$976M	$1.89B	$1.74B	$1.35B	$1.15B	$1.17B	$1.13B	$1.26B	-$377M	$488M	$513M	$327M	$231M	$119.86M	$210.2M	$165.77M	$90.04M
Interest Expense	+20.4%	+13.5%	+11.3%	—	$209M	$192M	$118M	$109M	$110M	$120M	$102M	$87M	$115M	$118M	$101M	$66M	$57M	$52M	$16.77M	$15.52M	$15.51M	$13.78M
Other Non-Operating Income	—	—	—	—	-$109M	—	—	-$109M	-$110M	-$145M	-$117M	-$72M	-$132M	-$57M	-$101M	-$65M	-$58M	-$56M	-$17.71M	-$15.52M	-$15.51M	—
Pretax Income	-17.9%	-9.3%	+6.2%	—	-$6M	$589M	$1.59B	$1.46B	$1.06B	$875M	$961M	$972M	$999M	-$612M	$205M	$322M	$135M	$81M	$23.38M	$120.3M	$89.49M	$38.16M
Income Tax	-24.4%	-16.5%	-4.2%	—	$1M	$117M	$410M	$373M	$271M	$216M	$288M	$235M	$292M	-$100M	$153M	$179M	$73M	$36M	$10.51M	$42.91M	$34.52M	$7.29M
Net Income	-15.8%	-6.8%	+12.7%	—	-$7M	$472M	$1.18B	$1.09B	$792M	$659M	$673M	$737M	$707M	-$512M	$52M	$143M	$62M	$53M	$9.79M	$20.82M	$54.97M	$30.87M
Net Margin	—	—	—	—	—	1.04%	2.9%	3.2%	2.48%	2.37%	3.46%	4.38%	3.74%	-2.58%	0.29%	1.01%	0.64%	0.8%	0.17%	0.46%	1.35%	0.84%
Comprehensive Income	-5.1%	-5.1%	+14.5%	—	-$13M	$544M	$1.2B	$1.17B	$637M	$617M	$706M	$749M	$705M	-$515M	$54M	$140M	$62M	$52M	$10.74M	$21.61M	$54.59M	$31.37M
EPS (Basic) USD/shares	-13.3%	-4.8%	+12.5%	—	$0.17	$8.93	$20.52	$18.91	$13.72	$11.40	$11.40	$11.85	$11.57	-$9.07	$0.93	$2.75	$1.33	$1.16	$0.21	$0.45	$1.34	$0.80
EPS (Diluted) USD/shares	-13.0%	-4.5%	+13.2%	at least $2.15	$0.18	$8.92	$20.42^G	$18.77	$13.55	$11.25^G	$11.23^G	$11.47	$10.61	-$9.07	$0.92	$2.58	$1.29	$1.13	$0.21	$0.45	$1.32	$0.79
Shares Outstanding (Basic Avg) shares	-3.0%	-2.2%	+0.2%	—	—	52.8M	57.4M	57.7M	57.8M	57.8M	59M	62.2M	61.1M	56.4M	55.4M	52M	47M	46M	46.38M	45.76M	41.17K	38.77M
Shares Outstanding (Diluted Avg) shares	-3.3%	-2.5%	-0.6%	—	—	52.9M	57.7M	58.1M	58.5M	58.6M	59.9M	64.2M	66.6M	56.4M	56.2M	56M	48M	47M	47M	46.43M	41.63K	38.98M

Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2009–FY2025: $3.27B in buybacks.

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue

—

Peer median 0.28×

EV/EBIT

—

Peer median 18.02×

P/E (TTM)

—

Peer median 22.16×

Peer medians compare against the 8 similar-size Healthcare Plans companies (of 13 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component	FY2025	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Medicare	$1,566,000,000	$4,227,000,000	$3,824,000,000	$3,379,000,000	$2,529,000,000	$2,265,000,000	—	—
Health Plans	—	—	—	—	—	—	$18,471,000,000	$19,352,000,000
Marketplace	—	$2,062,000,000	$2,296,000,000	$3,091,000,000	$1,677,000,000	$1,538,000,000	—	—
Medicaid	—	$27,707,000,000	$25,783,000,000	$21,231,000,000	$15,217,000,000	$13,026,000,000	—	—
Other Program	—	$76,000,000	$71,000,000	$70,000,000	$0	$0	—	—
All Other Segments	—	—	—	—	—	—	$419,000,000	$531,000,000

Key facts CIK 1179929 CUSIP 60855R100 13F (30d) 12 filings 11 filers Visit website Investor relations